Recombinant multi-species CA6/CA-VI protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CA6/CA-VI protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is one of several isozymes of carbonic anhydrase. This protein is found only in salivary glands and saliva and protein may play a role in the reversible hydratation of carbon dioxide though its function in saliva is unknown. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CA6, CA-VI,Carbonic anhydrase 6,Carbonate dehydratase VI, Carbonic anhydrase VI (CA-VI), Salivary carbonic anhydrase, Secreted carbonic anhydrase,CA-VI,GUSTIN
Go
to CA6/CA-VI products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T06569-Ab-1/ GM-Tg-hg-T06569-Ab-2 | Human CA6/CA-VI protein | Human |
GM-Tg-rg-T06569-Ab-1/ GM-Tg-rg-T06569-Ab-2 | Rat CA6/CA-VI protein | Rat |
GM-Tg-mg-T06569-Ab-1/ GM-Tg-mg-T06569-Ab-2 | Mouse CA6/CA-VI protein | Mouse |
GM-Tg-cynog-T06569-Ab-1/ GM-Tg-cynog-T06569-Ab-2 | Cynomolgus/Rhesus macaque CA6/CA-VI monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T06569-Ab-1/ GM-Tg-felg-T06569-Ab-2 | Feline CA6/CA-VI protein | Feline |
GM-Tg-cang-T06569-Ab-1/ GM-Tg-cang-T06569-Ab-2 | Canine CA6/CA-VI protein | Canine |
GM-Tg-bovg-T06569-Ab-1/ GM-Tg-bovg-T06569-Ab-2 | Bovine CA6/CA-VI protein | Bovine |
GM-Tg-equg-T06569-Ab-1/ GM-Tg-equg-T06569-Ab-2 | Equine CA6/CA-VI protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T06569-Ab-1/ GM-Tg-hg-T06569-Ab-2;
GM-Tg-rg-T06569-Ab-1/ GM-Tg-rg-T06569-Ab-2;
GM-Tg-mg-T06569-Ab-1/ GM-Tg-mg-T06569-Ab-2; GM-Tg-cynog-T06569-Ab-1/ GM-Tg-cynog-T06569-Ab-2; GM-Tg-felg-T06569-Ab-1/ GM-Tg-felg-T06569-Ab-2; GM-Tg-cang-T06569-Ab-1/ GM-Tg-cang-T06569-Ab-2; GM-Tg-bovg-T06569-Ab-1/ GM-Tg-bovg-T06569-Ab-2; GM-Tg-equg-T06569-Ab-1/ GM-Tg-equg-T06569-Ab-2 |
Products Name | CA6/CA-VI protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | CA6/CA-VI |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CA6/CA-VI protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.